Meta-analyses of microarray datasets identifies ANO1 and FADD as prognostic markers of head and neck cancer

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Reddy, Ram Bhupal ^a,b   Bhat, Anupama Rajan ^c   James, Bonney Lee ^a   Govindan, Sindhu Valiyaveedan ^a   Mathew, Rohit ^a   Ravindra, D R ^a   Hedne, Naveen ^a   Illiayaraja, Jeyaram ^a   Kekatpure, Vikram ^a   Khora, Samanta S ^b   Hicks, Wesley ^d   Tata, Pramila ^c   Kuriakose, Moni A ^a,d   Suresh, Amritha ^a  

^a Bommasandra Industrial Area   (India)

^b VIT UNIVERSITY   (India)

^c Kirloskar Business Park ^*  (India)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANO1 PROTEIN, HUMAN; CHLORIDE CHANNEL; FADD PROTEIN, HUMAN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

GENETICS; HEAD AND NECK TUMOR; HUMAN; META ANALYSIS; METABOLISM; PATHOLOGY; PROGNOSIS; VALIDATION STUDY;

BIOMARKERS, TUMOR; CHLORIDE CHANNELS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM PROTEINS; PROGNOSIS;

EID: 84983684580     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147409     Document Type: Article

References (61)

1. Madden SF, Clarke C, Gaule P, Aherne ST, O'Donovan N, Clynes M, et al. BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome. Breast cancer research: BCR. 2013; 15(4):R52. doi: 10.1186/bcr3444 PMID: 23820017; PubMed Central PMCID: PMC3978487.
2. Ademuyiwa FO, Miller A, O'Connor T, Edge SB, Thorat MA, Sledge GW, et al. The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort. Breast cancer research and treatment. 2011; 126(3):797-802. doi: 10.1007/s10549-010-1329-6 PMID: 21197567.
3. Carles A, Millon R, Cromer A, Ganguli G, Lemaire F, Young J, et al. Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display. Oncogene. 2006; 25 (12):1821-31. doi: 10.1038/sj.onc.1209203 PMID: 16261155.
4. Capkova M, Sachova J, Strnad H, Kolar M, Hroudova M, Chovanec M, et al. Microarray analysis of serum mRNA in patients with head and neck squamous cell carcinoma at whole-genome scale. BioMed research international. 2014; 2014:408683. doi: 10.1155/2014/408683 PMID: 24864240; PubMed Central PMCID: PMC4017838.
5. Rickman DS, Millon R, De Reynies A, Thomas E, Wasylyk C, Muller D, et al. Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays. Oncogene. 2008; 27(51):6607-22. doi: 10.1038/onc.2008. 251 PMID: 18679425.
6. Wu W, Tang X, Hu W, Lotan R, Hong WK, Mao L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clinical & experimental metastasis. 2002; 19(4):319-26. PMID: 12090472.
7. Roesch-Ely M, Nees M, Karsai S, Ruess A, Bogumil R, Warnken U, et al. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene. 2007; 26(1):54-64. doi: 10.1038/sj.onc.1209770 PMID: 16819514.
8. Luo Z, Zhang L, Li Z, Li X, Li G, Yu H, et al. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC medical genomics. 2012; 5:3.
9. Suresh A, Vannan M, Kumaran D, Gumus ZH, Sivadas P, Murugaian EE, et al. Resistance/response molecular signature for oral tongue squamous cell carcinoma. Disease markers. 2012; 32(1):51-64. doi: 10.3233/DMA-2012-0860 PMID: 22297602; PubMed Central PMCID: PMC3826923.
10. Stiekema J, Boot H, Aleman BM, Wessels LF, van Sandick JW. Prognostication and prediction using gene expression profiling in oesophageal cancer. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2013; 39 (1):17-23. doi: 10.1016/j.ejso.2012.07.008 PMID: 22840877.
11. Ziober AF, D'Alessandro L, Ziober BL. Is gene expression profiling of head and neck cancers ready for the clinic? Biomarkers in medicine. 2010; 4(4):571-80. doi: 10.2217/bmm.10.71 PMID: 20701444.
12. Goonesekere NC, Wang X, Ludwig L, Guda C. A meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers. PloS one. 9(4):e93046. PMID: 24740004. doi: 10. 1371/journal.pone.0093046
13. Wang XY, Hao JW, Zhou RJ, Zhang XS, Yan TZ, Ding DG, et al. Meta-analysis of gene expression data identifies causal genes for prostate cancer. Asian Pac J Cancer Prev. 14(1):457-61. PMID: 23534773.
14. Gyorffy B, Schafer R. Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients. Breast cancer research and treatment. 2009; 118(3):433-41. PMID: 19052860. doi: 10.1007/s10549-008-0242-8
15. Mihaly Z, Kormos M, Lanczky A, Dank M, Budczies J, Szasz MA, et al. A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer. Breast cancer research and treatment. 140(2):219-32. PMID: 23836010. doi: 10.1007/s10549-013-2622-y
16. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine. 2009; 6(7):e1000097. doi: 10.1371/journal.pmed.1000097 PMID: 19621072; PubMed Central PMCID: PMC2707599.
17. Ramasamy A, Mondry A, Holmes CC, Altman DG. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS medicine. 2008; 5(9):e184. PMID: 18767902. doi: 10.1371/journal.pmed.0050184
18. Mi H, Muruganujan A, Thomas PD. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic acids research. 2013; 41(Database issue):D377-86. doi: 10.1093/nar/gks1118 PMID: 23193289; PubMed Central PMCID: PMC3531194.
19. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, et al. STRING v9.1: proteinprotein interaction networks, with increased coverage and integration. Nucleic acids research. 2013; 41 (Database issue):D808-15. doi: 10.1093/nar/gks1094 PMID: 23203871; PubMed Central PMCID: PMC3531103.
20. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. Journal of biomedical informatics. 2011; 44(5):839-47. doi: 10.1016/j.jbi.2011.05.002 PMID: 21605702.
21. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer discovery. 2012; 2 (5):401-4. doi: 10.1158/2159-8290.CD-12-0095 PMID: 22588877; PubMed Central PMCID: PMC3956037.
22. Roldan Urgoiti GB, Gustafson K, Klimowicz AC, Petrillo SK, Magliocco AM, Doll CM. The prognostic value of HPV status and p16 expression in patients with carcinoma of the anal canal. PloS one. 2014; 9 (10):e108790. doi: 10.1371/journal.pone.0108790 PMID: 25271758; PubMed Central PMCID: PMC4182745.
23. Xie F, Xiao P, Chen D, Xu L, Zhang B. miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs. Plant molecular biology. 2012. doi: 10.1007/s11103-012-9885-2 PMID: 22290409.
24. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic acids research. 2001; 29(9):e45. PMID: 11328886; PubMed Central PMCID: PMC55695.
25. Lunde ML, Warnakulasuriya S, Sand L, Hirsch JM, Vasstrand EN, Ibrahim SO. Gene expression analysis by cDNA microarray in oral cancers from two Western populations. Anticancer research. 2010; 30 (4):1083-91. PMID: 20530413.
26. Ginos MA, Page GP, Michalowicz BS, Patel KJ, Volker SE, Pambuccian SE, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer research. 2004; 64(1):55-63. PMID: 14729608.
27. Yang Z, Chen Y, Fu Y, Yang Y, Zhang Y, Chen Y, et al. Meta-analysis of differentially expressed genes in osteosarcoma based on gene expression data. BMC medical genetics. 15:80. PMID: 25023069. doi: 10.1186/1471-2350-15-80
28. De Cecco L, Bossi P, Locati L, Canevari S, Licitra L. Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor. Ann Oncol. 25(8):1628-35. PMID: 24827125. doi: 10.1093/annonc/mdu173
29. De Cecco L, Nicolau M, Giannoccaro M, Daidone MG, Bossi P, Locati L, et al. Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data. Oncotarget. 2015; 6(11):9627-42. PMID: 25821127; PubMed Central PMCID: PMC4496244.
30. Cancer Genome Atlas N. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015; 517(7536):576-82. doi: 10.1038/nature14129 PMID: 25631445; PubMed Central PMCID: PMC4311405.
31. Katoh M, Katoh M. FLJ10261 gene, located within the CCND1-EMS1 locus on human chromosome 11q13, encodes the eight-transmembrane protein homologous to C12orf3, C11orf25 and FLJ34272 gene products. International journal of oncology. 2003; 22(6):1375-81. PMID: 12739008.
32. Duvvuri U, Shiwarski DJ, Xiao D, Bertrand C, Huang X, Edinger RS, et al. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer research. 2012; 72 (13):3270-81. doi: 10.1158/0008-5472.CAN-12-0475-T PMID: 22564524; PubMed Central PMCID: PMC3694774.
33. Ayoub C, Wasylyk C, Li Y, Thomas E, Marisa L, Robe A, et al. ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines. British journal of cancer. 2010; 103(5):715-26. doi: 10.1038/sj.bjc.6605823 PMID: 20664600; PubMed Central PMCID: PMC2938263.
34. Shiwarski DJ, Shao C, Bill A, Kim J, Xiao D, Bertrand CA, et al. To "grow" or "go": TMEM16A expression as a switch between tumor growth and metastasis in SCCHN. Clinical cancer research: an official journal of the American Association for Cancer Research. 2014; 20(17):4673-88. doi: 10.1158/1078-0432.CCR-14-0363 PMID: 24919570; PubMed Central PMCID: PMC4160843.
35. Li Y, Zhang J, Yang K, Zhang F, Chen R, Chen D. [Effects of stable ANO1 overexpression on biological behaviors of human laryngeal squamous cell carcinoma Hep-2 cells in vitro]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 2014; 34(2):251-5. PMID: 24589607.
36. McDonald ER 3rd, Chui PC, Martelli PF, Dicker DT, El-Deiry WS. Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signaling. The Journal of biological chemistry. 2001; 276(18):14939-45. doi: 10.1074/jbc.M100399200 PMID: 11279061.
37. Fan S, Muller S, Chen ZG, Pan L, Tighiouart M, Shin DM, et al. Prognostic impact of Fas-associated death domain, a key component in death receptor signaling, is dependent on the presence of lymph node metastasis in head and neck squamous cell carcinoma. Cancer biology & therapy. 2013; 14 (4):365-9. doi: 10.4161/cbt.23636 PMID: 23358467; PubMed Central PMCID: PMC3667877.
38. Pattje WJ, Melchers LJ, Slagter-Menkema L, Mastik MF, Schrijvers ML, Gibcus JH, et al. FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck. Histopathology. 2013; 63(2):263-70. doi: 10.1111/his.12174 PMID: 23763459.
39. Jarmuz-Szymczak M, Pelinska K, Kostrzewska-Poczekaj M, Bembnista E, Giefing M, Brauze D, et al. Heterogeneity of 11q13 region rearrangements in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization. Molecular biology reports. 2013; 40 (7):4161-71. doi: 10.1007/s11033-013-2496-4 PMID: 23652995.
40. Gibcus JH, Menkema L, Mastik MF, Hermsen MA, de Bock GH, van Velthuysen ML, et al. Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2007; 13(21):6257-66.
41. Choi EJ, Yun JA, Jabeen S, Jeon EK, Won HS, Ko YH, et al. Prognostic significance of TMEM16A, PPFIA1, and FADD expression in invasive ductal carcinoma of the breast. World journal of surgical oncology. 2014; 12:137.
42. Saito S, Liu XF, Kamijo K, Raziuddin R, Tatsumoto T, Okamoto I, et al. Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation. The Journal of biological chemistry. 2004; 279(8):7169-79. PMID: 14645260.
43. Murata Y, Minami Y, Iwakawa R, Yokota J, Usui S, Tsuta K, et al. ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma. Cancer science. 105 (4):490-7. PMID: 24484057. doi: 10.1111/cas.12363
44. Sano M, Genkai N, Yajima N, Tsuchiya N, Homma J, Tanaka R, et al. Expression level of ECT2 protooncogene correlates with prognosis in glioma patients. Oncology reports. 2006; 16(5):1093-8. PMID: 17016598.
45. Iyoda M, Kasamatsu A, Ishigami T, Nakashima D, Endo-Sakamoto Y, Ogawara K, et al. Epithelial cell transforming sequence 2 in human oral cancer. PloS one. 5(11):e14082. PMID: 21124766. doi: 10. 1371/journal.pone.0014082
46. Kinsey C, Balakrishnan V, O'Dell MR, Huang JL, Newman L, Whitney-Miller CL, et al. Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression. Cell reports. 7(4):1143-55. PMID: 24794439. doi: 10.1016/j.celrep.2014.03.061
47. Yu Y, Dong W, Li X, Yu E, Zhou X, Li S. Significance of c-Myc and Bcl-2 protein expression in nasopharyngeal carcinoma. Archives of otolaryngology-head & neck surgery. 2003; 129(12):1322-6. doi: 10. 1001/archotol.129.12.1322 PMID: 14676159.
48. Mourtada-Maarabouni M, Watson D, Munir M, Farzaneh F, Williams GT. Apoptosis suppression by candidate oncogene PLAC8 is reversed in other cell types. Current cancer drug targets. 13(1):80-91. PMID: 22920440.
49. Santarpia L, Iwamoto T, Di Leo A, Hayashi N, Bottai G, Stampfer M, et al. DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes. The oncologist. 2013; 18 (10):1063-73. doi: 10.1634/theoncologist.2013-0163 PMID: 24072219; PubMed Central PMCID: PMC3805146.
50. Zhang L, Sui Y, Wang T, Li L, Li Y, Jin C, et al. [Roles of hMMS2 gene in reversing the oxaliplatin tolerance of human colon carcinoma cells]. Yi chuan = Hereditas / Zhongguo yi chuan xue hui bian ji. 2014; 36(4):346-53. PMID: 24846979.
51. Yom SS. HPV and oropharyngeal cancer: etiology and prognostic importance. Seminars in cutaneous medicine and surgery. 2015; 34(4):178-81. doi: 10.12788/j.sder.2015.0182 PMID: 26650695.
52. Elango KJ, Suresh A, Erode EM, Subhadradevi L, Ravindran HK, Iyer SK, et al. Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev. 2011; 12(4):889-96. PMID: 21790221.
53. Toner M, O'Regan EM. Head and neck squamous cell carcinoma in the young: a spectrum or a distinct group? Part 2. Head and neck pathology. 2009; 3(3):249-51. doi: 10.1007/s12105-009-0137-y PMID: 20596980; PubMed Central PMCID: PMC2811629.
54. Westra WH. The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head and neck pathology. 2009; 3(1):78-81. doi: 10.1007/s12105-009-0100-y PMID: 20596995; PubMed Central PMCID: PMC2807531.
55. Filippova M, Parkhurst L, Duerksen-Hughes PJ. The human papillomavirus 16 E6 protein binds to Fasassociated death domain and protects cells from Fas-triggered apoptosis. The Journal of biological chemistry. 2004; 279(24):25729-44. doi: 10.1074/jbc.M401172200 PMID: 15073179.
56. Choi P, Chen C. Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma. Cancer. 2005; 104(6):1113-28. doi: 10.1002/cncr.21293 PMID: 16092115.
57. Yu L, Lu S, Tian J, Ma J, Li J, Wang H, et al. TWIST expression in hypopharyngeal cancer and the mechanism of TWIST-induced promotion of metastasis. Oncology reports. 2012; 27(2):416-22. doi: 10.3892/or.2011.1481 PMID: 21971638.
58. Pacheco MM, Kowalski LP, Nishimoto IN, Brentani MM. Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs. Head & neck. 2002; 24(1):24-32. PMID: 11774399.
59. Bhattacharya N, Roy A, Roy B, Roychoudhury S, Panda CK. MYC gene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients. Journal of oral pathology & medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2009; 38(10):759-63. doi: 10.1111/j.1600-0714.2009.00781.x PMID: 19453846.
60. Gapany M, Pavelic ZP, Kelley DJ, Pavelic L, Gapany SR, Craven JM, et al. Immunohistochemical detection of c-myc protein in head and neck tumors. Archives of otolaryngology-head & neck surgery. 1994; 120(3):255-9. PMID: 8123232.
61. Akervall J, Bockmuhl U, Petersen I, Yang K, Carey TE, Kurnit DM. The gene ratios c-MYC:cyclindependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck. Clinical cancer research: an official journal of the American Association for Cancer Research. 2003; 9(5):1750-5. PMID: 12738730.